Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-based Triple and Reverse Hybrid Therapies vs Standard PPI Triple Therapy for Helicobacter pylori Eradication
TCTR20260718001Recruiting
- Sponsor
- Department of Gastroenterology, Maharajgunj Medical Campus, TU Teaching Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of vonoprazan in Helicobacter pylori infection (3 arms), sponsored by Department of Gastroenterology, Maharajgunj Medical Campus, TU Teaching Hospital. Started May 2026; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on TCTR20260718001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260718001.